TDAM USA’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,106
Closed -$810K 366
2016
Q4
$810K Buy
10,106
+10
+0.1% +$794 0.04% 240
2016
Q3
$805K Sell
10,096
-5,585
-36% -$451K 0.04% 247
2016
Q2
$1.22M Sell
15,681
-20
-0.1% -$1.43K 0.06% 203
2016
Q1
$864K Sell
15,701
-398
-2% -$21.7K 0.04% 243
2015
Q4
$994K Buy
16,099
+3,842
+31% +$242K 0.05% 231
2015
Q3
$773K Sell
12,257
-170
-1% -$12.1K 0.04% 256
2015
Q2
$908K Hold
12,427
0.04% 253
2015
Q1
$813K Buy
12,427
+65
+0.5% +$4.32K 0.03% 273
2014
Q4
$804K Sell
12,362
-110
-0.9% -$7.08K 0.03% 189
2014
Q3
$750K Buy
12,472
+381
+3% +$24.9K 0.03% 198
2014
Q2
$837K Sell
12,091
-585
-5% -$37.9K 0.04% 197
2014
Q1
$829K Sell
12,676
-683
-5% -$44.5K 0.04% 195
2013
Q4
$828K Buy
13,359
+1,020
+8% +$59.1K 0.04% 195
2013
Q3
$662K Buy
+12,339
New +$635K 0.03% 163

Other funds holding STJ

TDAM USA's STJ Position: Q1 2017 in Review

TDAM USA sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,106 shares — an estimated $810K sold.

TDAM USA first reported a position in STJ in Q3 2013 and held it in 14 quarters. The position peaked at $1.22M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • TDAM USA reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • TDAM USA sold 10,106 St Jude Medical shares in Q1 2017, an estimated $810K.
  • TDAM USA first reported a position in St Jude Medical in Q3 2013 and held it in 14 quarters.
  • TDAM USA's St Jude Medical position peaked at $1.22M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on TDAM USA's 13F filing for Q1 2017, filed 5 May 2017.